Girl set for wheelchair by three still standing thanks to £64,000 injections hulldailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hulldailymail.co.uk Daily Mail and Mail on Sunday newspapers.
Dynacure announces publication of Hierarchical Bayesian modelling of disease progression in Orphanet Journal of Rare Diseases
Bayesian statistical approach based on natural history study could address clinical trial design challenges in centronuclear myopathy
News provided by
Share this article
Share this article
STRASBOURG, France and PHILADELPHIA, Jan. 15, 2021 /PRNewswire/ Dynacure, a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options, announced the publication of a paper entitled,
Hierarchical Bayesian modelling of disease progression to inform clinical trial design in centronuclear myopathy (CNM). The paper was published this month in Orphanet Journal of Rare Diseases, a scientific, peer-reviewed publication and can be accessed here.